Tekla Capital Management LLC I Mab Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
A detailed history of Tekla Capital Management LLC transactions in I Mab stock. As of the latest transaction made, Tekla Capital Management LLC holds 162,580 shares of IMAB stock, worth $271,508. This represents 0.02% of its overall portfolio holdings.
Number of Shares
162,580
Previous 162,580
-0.0%
Holding current value
$271,508
Previous $562,000
13.52%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding IMAB
# of Institutions
45Shares Held
16MCall Options Held
11.9KPut Options Held
3.5K-
Hhlr Advisors, Ltd. Grand Cayman, E96.91MShares$11.5 Million0.29% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$6.96 Million3.04% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny617KShares$1.03 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY576KShares$961,2180.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U0567KShares$946,3050.01% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $139M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...